These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
202 related articles for article (PubMed ID: 32957517)
1. A Novel Cytotoxic Conjugate Derived from the Natural Product Podophyllotoxin as a Direct-Target Protein Dual Inhibitor. Hernández ÁP; Díez P; García PA; Pérez-Andrés M; Ortega P; Jambrina PG; Díez D; Castro MÁ; Fuentes M Molecules; 2020 Sep; 25(18):. PubMed ID: 32957517 [TBL] [Abstract][Full Text] [Related]
2. Design, synthesis, biological evaluation, and 3D-QSAR analysis of podophyllotoxin-dioxazole combination as tubulin targeting anticancer agents. Wang ZZ; Sun WX; Wang X; Zhang YH; Qiu HY; Qi JL; Pang YJ; Lu GH; Wang XM; Yu FG; Yang YH Chem Biol Drug Des; 2017 Aug; 90(2):236-243. PubMed ID: 28079286 [TBL] [Abstract][Full Text] [Related]
3. Synthesis and biological evaluation of podophyllotoxin congeners as tubulin polymerization inhibitors. Kamal A; Srinivasa Reddy T; Polepalli S; Shalini N; Reddy VG; Subba Rao AV; Jain N; Shankaraiah N Bioorg Med Chem; 2014 Oct; 22(19):5466-75. PubMed ID: 25131956 [TBL] [Abstract][Full Text] [Related]
4. Identification of potent virtual leads and ADME prediction of isoxazolidine podophyllotoxin derivatives as topoisomerase II and tubulin inhibitors. Bkhaitan MM; Mirza AZ; Shamshad H; Ali HI J Mol Graph Model; 2017 May; 73():74-93. PubMed ID: 28242581 [TBL] [Abstract][Full Text] [Related]
5. Podophyllic Aldehyde, a Podophyllotoxin Derivate, Elicits Different Cell Cycle Profiles Depending on the Tumor Cell Line: A Systematic Proteomic Analysis. Hernández ÁP; Chaparro-González L; Garzo-Sánchez O; Arias-Hidalgo C; Juanes-Velasco P; García PA; Castro MÁ; Fuentes M Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38731850 [TBL] [Abstract][Full Text] [Related]
6. Cytotoxic cyclolignans related to podophyllotoxin. Gordaliza M; Miguel del Corral JM; Angeles Castro M; García-García PA; San Feliciano A Farmaco; 2001 Apr; 56(4):297-304. PubMed ID: 11421258 [TBL] [Abstract][Full Text] [Related]
7. Antileishmanial activity and tubulin polymerization inhibition of podophyllotoxin derivatives on Leishmania infantum. Escudero-Martínez JM; Pérez-Pertejo Y; Reguera RM; Castro MÁ; Rojo MV; Santiago C; Abad A; García PA; López-Pérez JL; San Feliciano A; Balaña-Fouce R Int J Parasitol Drugs Drug Resist; 2017 Dec; 7(3):272-285. PubMed ID: 28719882 [TBL] [Abstract][Full Text] [Related]
8. Novel Podophyllotoxin Derivatives as Potential Tubulin Inhibitors: Design, Synthesis, and Antiproliferative Activity Evaluation. Han HW; Lin HY; He DL; Ren Y; Sun WX; Liang L; Du MH; Li DC; Chu YC; Yang MK; Wang XM; Yang YH Chem Biodivers; 2018 Nov; 15(11):e1800289. PubMed ID: 30194898 [TBL] [Abstract][Full Text] [Related]
9. Design, Synthesis and Cancer Cell Growth Inhibition Evaluation of New Aminoquinone Hybrid Molecules. Defant A; Mancini I Molecules; 2019 Jun; 24(12):. PubMed ID: 31197105 [TBL] [Abstract][Full Text] [Related]
10. Synthesis and biological evaluation of a series of podophyllotoxins derivatives as a class of potent antitubulin agents. Liu Y; Wei D; Zhao Y; Cheng W; Lu Y; Ma Y; Li X; Han C; Wei Y; Cao H; Zhao C Bioorg Med Chem; 2012 Nov; 20(21):6285-95. PubMed ID: 23022053 [TBL] [Abstract][Full Text] [Related]
11. Design, synthesis and biological evaluation of novel podophyllotoxin derivatives as tubulin-targeting anticancer agents. Guo Y; Chen B; Guo J; Jiang P; Wang J; Sun W Pharm Biol; 2024 Dec; 62(1):233-249. PubMed ID: 38393642 [TBL] [Abstract][Full Text] [Related]
12. Scaffold overlay of flavonoid-inspired molecules: Discovery of 2,3-diaryl-pyridopyrimidin-4-imine/ones as dual hTopo-II and tubulin targeting anticancer agents. Saini M; Paul S; Acharya A; Acharya SS; Kundu CN; Guchhait SK Bioorg Chem; 2024 Nov; 152():107738. PubMed ID: 39182257 [TBL] [Abstract][Full Text] [Related]
13. Synthesis and biological evaluation of benzo[b]furo[3,4-e][1,4]diazepin-1-one derivatives as anti-cancer agents. Malayeri SO; Tayarani-Najaran Z; Behbahani FS; Rashidi R; Delpazir S; Ghodsi R Bioorg Chem; 2018 Oct; 80():631-638. PubMed ID: 30041139 [TBL] [Abstract][Full Text] [Related]
14. Investigation of podophyllotoxin esters as potential anticancer agents: synthesis, biological studies and tubulin inhibition properties. Shareef MA; Duscharla D; Ramasatyaveni G; Dhoke NR; Das A; Ummanni R; Srivastava AK Eur J Med Chem; 2015 Jan; 89():128-37. PubMed ID: 25462233 [TBL] [Abstract][Full Text] [Related]
15. SAR analysis and biological studies of synthesized podophyllum derivates obtained by N linkage modification at C-4 position. Wang H; Tang L; Tang Y; Yuan Z Bioorg Med Chem; 2014 Nov; 22(21):6183-92. PubMed ID: 25282651 [TBL] [Abstract][Full Text] [Related]
16. Antitumor properties of podophyllotoxin and related compounds. Gordaliza M; Castro MA; del Corral JM; Feliciano AS Curr Pharm Des; 2000 Dec; 6(18):1811-39. PubMed ID: 11102564 [TBL] [Abstract][Full Text] [Related]
17. Cytotoxic Cyclolignans Obtained by the Enlargement of the Cyclolignan Skeleton of Podophyllic Aldehyde, a Selective Podophyllotoxin-Derived Cyclolignan. García PA; Hernández ÁP; Gómez-Zurita MA; Miguel Del Corral JM; Gordaliza M; Francesch A; San Feliciano A; Castro MÁ Molecules; 2024 Mar; 29(7):. PubMed ID: 38611722 [TBL] [Abstract][Full Text] [Related]
18. Synthesis and Biological Activity of Ferrocenyl and Ruthenocenyl Analogues of Etoposide: Discovery of a Novel Dual Inhibitor of Topoisomerase II Activity and Tubulin Polymerization. Chrabąszcz K; Błauż A; Gruchała M; Wachulec M; Rychlik B; Plażuk D Chemistry; 2021 Apr; 27(20):6254-6262. PubMed ID: 33465263 [TBL] [Abstract][Full Text] [Related]
19. Podophyllotoxin analogs: effects on DNA topoisomerase II, tubulin polymerization, human tumor KB cells, and their VP-16-resistant variants. Liu SY; Hwang BD; Haruna M; Imakura Y; Lee KH; Cheng YC Mol Pharmacol; 1989 Jul; 36(1):78-82. PubMed ID: 2546053 [TBL] [Abstract][Full Text] [Related]
20. Synthesis and biological evaluation of cytotoxic activity of novel podophyllotoxin derivatives incorporating piperazinyl-cinnamic amide moieties. Zhang X; Yang T; Jin X; Lin K; Dai X; Gao T; Huang G; Fan M; Ma L; Liu Z; Cao J Bioorg Chem; 2022 Jun; 123():105761. PubMed ID: 35358823 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]